Therapeutic Asset Ratings

13,145 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
ct1812 Lewy Body Dementia	Cognition Therapeutics	P2	B (57)
ct-868 Type 2 Diabetes Mellitus	Carmot Therapeutics, Inc.	P2	B (57)
Cyclophosphamide Autoimmune Hemolytic Anemia	City of Hope Medical Center	P2	B (57)
Cyclophosphamide Beta Thalassemia	Memorial Sloan Kettering Cancer Center	P2	B (57)
Cyclophosphamide Therapy-Related Myeloid Neoplasm	M.D. Anderson Cancer Center	P2	B (57)
Cyclophosphamide Hemophagocytic Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
Cyclophosphamide Langerhans Cell Histiocytosis	M.D. Anderson Cancer Center	P2	B (57)
Cyclophosphamide X-Linked Lymphoproliferative Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
Cyclosporin A Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	University of Michigan Rogel Cancer Center	P2	B (57)
Cytarabine Core Binding Factor Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	B (57)
Cytarabine Mixed Phenotype Acute Leukemia,T/Myeloid	yuejun Liu	P2	B (57)
Cytarabine Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
da-1241 Metabolic Dysfunction-Associated Steatohepatitis	NeuroBo Pharmaceuticals Inc.	P2	B (57)
Dabrafenib Colorectal Cancer	Tianjin Medical University Cancer Institute and Hospital	P2	B (57)
Dapagliflozin Depressive Disorder	Tanta University	P2	B (57)
Dapagliflozin Cirrhosis Of Liver	AstraZeneca	P2	B (57)
Daridorexant Cognitive Disorder	University of Rochester	P2	B (57)
Daridorexant Delirium	University of Rochester	P2	B (57)
Darolutamide Triple-Negative Breast Carcinoma	Vandana Abramson	P2	B (57)
Darovasertib Ocular Melanoma	St Vincent's Hospital, Sydney	P2	B (57)
Dasatinib Breast Cancer	National Cancer Institute (NCI)	P2	B (57)
Dasatinib Cognitive Disorder	Mayo Clinic	P2	B (57)
Datopotamab Deruxtecan Triple-Negative Breast Carcinoma	UNC Lineberger Comprehensive Cancer Center	P2	B (57)
Daunomycin Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	B (57)
Daunomycin Core Binding Factor Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	B (57)

Showing 3001 to 3025 of 13,145 assets

PreviousPage 121 of 526Next